Short Seller Marc Cohodes Confronts Pharma Fraud's Ringleader: Part Three

This is the third part of the groundbreaking January 2019 interview between Real Vision co-founder Grant Williams and legendary short seller Marc Cohodes. In this clip, Cohodes continues the story of his battle to expose the truth with pharmaceutical giant, MiMedx. Specifically, he speaks about confronting the former CEO of the company, Pete Petit. This clip is excerpted from a video published on Real Vision on February 1, 2019 entitled “Fraud, Intimidation and Truth: Marc Cohodes’ Last Stand.”

Watch more Real Vision™ videos: http://po.st/RealVisionVideos
Subscribe to Real Vision™ on YouTube: http://po.st/RealVisionSubscribe
Watch more by starting your 14-day free trial here:
https://rvtv.io/2xdIDmo

About The Interview:
The smartest minds in finance sit down for incredibly deep-diving discussions. Peer-to-peer conversations between the rock stars of the financial world.

About Real Vision™:
Real Vision™ is the destination for the world’s most successful investors to share their thoughts about what’s happening in today's markets. Think: TED Talks for Finance. On Real Vision™ you get exclusive access to watch the most successful investors, hedge fund managers and traders who share their frank and in-depth investment insights with no agenda, hype or bias. Make smart investment decisions and grow your portfolio with original content brought to you by the biggest names in finance, who get to say what they really think on Real Vision™.

Connect with Real Vision™ Online:
Twitter: https://rvtv.io/2p5PrhJ
Instagram: https://rvtv.io/2J7Ddlw
Facebook: https://rvtv.io/2NNOlmu
Linkedin: https://rvtv.io/2xbskqx

Short Seller Marc Cohodes Confronts Pharma Fraud's Ringleader: Part Three
   / realvisiontelevision  

Transcript:
For the full transcript visit: https://rvtv.io/2xdIDmo
MARC COHODES: Hello, Parker.
PARKER PETIT: It's sort of my pleasure.
MARC COHODES: Here, I'll come up and shake hands with you.
PARKER PETIT: Well, I'm not tall enough to shake hands with you.
MARC COHODES: You're not, but you can-- here, I'll sit down next to you.
PARKER PETIT: All right.
MARC COHODES: Hello, Chris. Parker, I'm right here, OK?
PARKER PETIT: I don't really want you here.
MARC COHODES: Even when I kneeled down on my knees I was taller than him. So I shake his
hand, and then we start getting into it about his accounting and his thing, and he was all wigged
out. And other people started picking up questions on it. And I knew some people in the room,
and they knew some of the issues that should be brought up like share-based compensation, which
didn't add, and when are you going to file your financials and your auditor and why don't you
have an independent investigation?
And he said something like, being the head of a public company, I have rules and laws I have to
abide to. He says if I don't tell the truth or I lie in my documents, I can go to jail. Well, that's
where you should go, and that's where you're going to end up, Parker, because you have lied.
You're a serial liar.
And I brought up all these issues, and there was a big hubbub on this jump, and I'm at the
meeting. But little did he know I was in the process through all of December and early January of
preparing documents outlining 12 steps of his fraud to send to his auditor, Ernst & Young in
Atlanta. And the JPMorgan conference was January 10th-ish, 8th-ish, something like that.
And I sent a package of a huge volume of material to their auditor at the end of January because
they had an audit that needed to be done, I think, by the end of February. And I figure I might as
well send the auditor everything I have on this thing, and I basically told Ernst & Young and the
auditor-- I think a fellow named Andrew Brock-- I'm not anonymous. Here's my name. Here's what
I've done. Here's what I see. Here's my evidence. Here we go. You have any questions, call me.
And I printed three copies, one for me, my attorney-- I also sent it all to the SEC at the same time
on a thumb drive-- me. I sent it to Andrew Brock at Ernst & Young, and I just kept another copy.
And all Ernst & Young did was say they received it. If they have any questions, they'd call me. No problem.